Bronchial artery embolization for haemoptysis in patients with lymphoma and leukaemia Review


Authors: Geevarghese, R.; Petre, E. N.; Ziv, E.; Santos, E.; Rodriguez, L.; Sotirchos, V. S.; Zhao, K.; Solomon, S. B.; Alexander, E. S.
Review Title: Bronchial artery embolization for haemoptysis in patients with lymphoma and leukaemia
Abstract: Haemoptysis in patients with lymphoma and leukaemia can present a therapeutic challenge, given that it is often associated with underlying impairments of haemostasis and immunosuppression. Bronchial artery embolization (BAE) is a mainstay in the treatment of haemoptysis, typically in those requiring emergent management. In this case series, the role of BAE in patients with lymphoma and leukaemia was evaluated. A total of 5 patients were identified between August 2010 and August 2022. Three patients were diagnosed with lymphoma (classical Hodgkin's lymphoma, diffuse large B-cell lymphoma and extra-nodal marginal zone lymphoma) and 2 patients were diagnosed with leukaemia (1 patient with acute myeloid leukaemia and the other with chronic lymphocytic leukaemia). All patients were thrombocytopenic [77.6 +/- 28.5 x 109/L (mean +/- SD)], at presentation. Three patients had concurrent lung infection at the time of their presentation. Technical success was achieved in 4/5 patients (80%). Clinical success was obtained in 4/5 patients (80%). Recurrence following embolization was seen in 2 patients. Three patients died within 30 days following embolization (from deteriorating respiratory function). Bronchial artery embolization for haemoptysis in patients with lymphoma and leukaemia is safe and feasible. Concurrent lung infection is potentially of significance with regard to initial presentation and overall outcomes following embolization. In select patients, BAE may provide a therapeutic option, though further investigation is required.
Keywords: lymphoma; disorders; leukaemia; bronchial artery embolization; haemoptysis
Journal Title: BJR Case Reports
Volume: 11
Issue: 4
ISSN: 2055-7159
Publisher: British Institute of Radiology  
Date Published: 2025-07-01
Start Page: uaaf036
Language: English
ACCESSION: WOS:001537455300001
DOI: 10.1093/bjrcr/uaaf036
PROVIDER: wos
PMCID: PMC12303864
PUBMED: 40735168
Notes: Review -- MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PubMed and PDF -- MSK corresponding author is Erica Alexander -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Stephen Solomon
    428 Solomon
  2. Elena Nadia Petre
    111 Petre
  3. Etay   Ziv
    116 Ziv
  4. Ken Zhao
    40 Zhao